These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25247344)

  • 21. [Postmenopausal osteoporosis. Bisphosphonates are not all equal].
    MMW Fortschr Med; 2009 Mar; 151(11):46-7. PubMed ID: 19469206
    [No Abstract]   [Full Text] [Related]  

  • 22. Ranking antireabsorptive agents to prevent vertebral fractures in postmenopausal osteoporosis by mixed treatment comparison meta-analysis.
    Migliore A; Broccoli S; Massafra U; Cassol M; Frediani B
    Eur Rev Med Pharmacol Sci; 2013 Mar; 17(5):658-67. PubMed ID: 23543450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reclast approved for osteoporosis treatment in postmenopausal women.
    Laustsen G
    Nurse Pract; 2007 Dec; 32(12):12-4. PubMed ID: 18043404
    [No Abstract]   [Full Text] [Related]  

  • 24. Bisphosphonates for osteoporosis.
    Favus MJ
    N Engl J Med; 2010 Nov; 363(21):2027-35. PubMed ID: 21083387
    [No Abstract]   [Full Text] [Related]  

  • 25. [Teriparatide: an anabolic drug for the treatment of patients with osteoporosis].
    Lems WF; Hamdy NA; Netelenbos JC
    Ned Tijdschr Geneeskd; 2006 Jan; 150(3):132-7. PubMed ID: 16463613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Teriparatide in bisphosphonate-resistant osteoporosis: microarchitectural changes and clinical results after 6 and 18 months.
    Jobke B; Muche B; Burghardt AJ; Semler J; Link TM; Majumdar S
    Calcif Tissue Int; 2011 Aug; 89(2):130-9. PubMed ID: 21626160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Up-to-date treatments for osteoporosis].
    Bors K
    Orv Hetil; 2006 Feb; 147(7):301-6. PubMed ID: 17489157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Teriparatide for postmenopausal osteoporosis.
    Drug Ther Bull; 2004 Dec; 42(12):93-5. PubMed ID: 15587764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Denosumab for postmenopausal osteoporosis?
    Drug Ther Bull; 2012 Jan; 50(1):6-8. PubMed ID: 22241889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of osteoporosis: one step forward, two steps back.
    Stevenson JC
    Menopause Int; 2011 Dec; 17(4):137-41. PubMed ID: 22120943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. One drug tackles two diseases.
    Br Dent J; 2005 Dec; 199(11):701. PubMed ID: 16341176
    [No Abstract]   [Full Text] [Related]  

  • 32. Back pain treatment in post-menopausal osteoporosis with vertebral fractures.
    Ulivieri FM
    Aging Clin Exp Res; 2007 Jun; 19(3 Suppl):21-3. PubMed ID: 18180603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost effectiveness of teriparatide and PTH(1-84) in the treatment of postmenopausal osteoporosis.
    Borgström F; Ström O; Marin F; Kutahov A; Ljunggren O
    J Med Econ; 2010; 13(3):381-92. PubMed ID: 20604678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study shows that a new type of osteoporosis drug reduces fracture risk.
    Harv Womens Health Watch; 2009 Oct; 17(2):6-7. PubMed ID: 19998553
    [No Abstract]   [Full Text] [Related]  

  • 35. Sustained nonvertebral fragility fracture risk reduction after discontinuation of teriparatide treatment.
    Prince R; Sipos A; Hossain A; Syversen U; Ish-Shalom S; Marcinowska E; Halse J; Lindsay R; Dalsky GP; Mitlak BH
    J Bone Miner Res; 2005 Sep; 20(9):1507-13. PubMed ID: 16059622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Denosumab (prolia) for treatment of postmenopausal osteoporosis.
    Johnson GL
    Am Fam Physician; 2012 Feb; 85(4):334-6. PubMed ID: 22335312
    [No Abstract]   [Full Text] [Related]  

  • 37. Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis.
    Gallagher JC; Rosen CJ; Chen P; Misurski DA; Marcus R
    Bone; 2006 Dec; 39(6):1268-75. PubMed ID: 16884968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety concerns with the long-term management of osteoporosis.
    Reginster JY; Pelousse F; Bruyère O
    Expert Opin Drug Saf; 2013 Jul; 12(4):507-22. PubMed ID: 23614635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of teriparatide on bone mineral density and fracture in postmenopausal osteoporosis: meta-analysis of randomised controlled trials.
    Han SL; Wan SL
    Int J Clin Pract; 2012 Feb; 66(2):199-209. PubMed ID: 22257045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of osteoporosis in an active female patient?].
    Fassbender WJ
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2416. PubMed ID: 18988136
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.